Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Kenneth Gordon

7PUBLICATIONS
24CO-AUTHORS
DermatologyAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Apr 04, 2025
Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.

Kenneth B Gordon, Yayoi Tada, Milan J Anadkat

|Feb 10, 2025
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.

Kenneth B Gordon, Yayoi Tada, Milan J Anadkat

|Mar 20, 2024
Bimekizumab for the treatment of psoriasis.

Molly Thapar, Milan Patel, Kenneth Gordon

|Nov 11, 2023
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials.

Kenneth B Gordon, Richard G Langley, Richard B Warren

|Oct 15, 2021
Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

K B Gordon, M Lebwohl, K A Papp

|Jun 09, 2021
Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2.

K Reich, K B Gordon, B E Strober

Pageof 2

Frequent Collaborators

3 joint publications

Kristian Reich

3 joint publications

Diamant Thaçi

2 joint publications

April W Armstrong

2 joint publications

Megan Miller

2 joint publications

Peter Foley

2 joint publications

Jonathan N Barker

2 joint publications

Milan J Anadkat

2 joint publications

Boni Elewski

2 joint publications

Siew Eng Choon

2 joint publications

Yayoi Tada

Frequent Collaborators

3 joint publications

Kristian Reich

3 joint publications

Diamant Thaçi

2 joint publications

April W Armstrong

2 joint publications

Megan Miller

Top Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

507
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

38.9K
See more related videos

Top Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

507
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

38.9K
See more related videos